These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15646499)

  • 21. [The clinical application of perfluorotributylamine liquid in the complicated retinal detachment].
    Zhu X; Jiang D
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):253-5. PubMed ID: 12016798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of perfluorocarbon liquids in vitreoretinal surgery.
    Crafoord S; Larsson J; Hansson LJ; Carlsson JO; Stenkula S
    Acta Ophthalmol Scand; 1995 Oct; 73(5):442-5. PubMed ID: 8751125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new curved vitreous cutter for managing phakic retinal detachment with proliferative vitreoretinopathy.
    Natarajan S; Malpani A; Nirmalan PK
    Indian J Ophthalmol; 1998 Jun; 46(2):87-9. PubMed ID: 9847480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Perfluorocarbon liquids in surgery of the vitreous body and retina].
    Faude F; Wolf S; Wiedemann P
    Ophthalmologe; 2000 Sep; 97(9):652-61. PubMed ID: 11147344
    [No Abstract]   [Full Text] [Related]  

  • 25. Retinal reattachment facilitated by short-term perfluorocarbon liquid tamponade in a case of fevr and rhegmatogenous retinal detachment.
    Shaikh S; Trese MT
    Retina; 2002 Oct; 22(5):674-6. PubMed ID: 12441744
    [No Abstract]   [Full Text] [Related]  

  • 26. [Epiretinal membranes: reasons not to perform vitreoretinal surgery].
    Bonnel S; Barale PO; Laroche L; Sahel JA; Monin C
    J Fr Ophtalmol; 2008 Feb; 31(2):200-7. PubMed ID: 18401323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Are heavy silicone oils unnecessary in vitreoretinal surgery?].
    Helbig H; Gabel VP
    Klin Monbl Augenheilkd; 2009 Sep; 226(9):705-6. PubMed ID: 19750419
    [No Abstract]   [Full Text] [Related]  

  • 28. Vitreous substitute and tamponade substances for microincision vitreoretinal surgery.
    Rizzo S; Barca F
    Dev Ophthalmol; 2014; 54():92-101. PubMed ID: 25196757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and control of proliferative vitreoretinopathy: primary retinal detachment surgery using silicone oil as a planned two-stage procedure in high-risk cases.
    Alexander P; Prasad R; Ang A; Poulson AV; Scott JD; Snead MP
    Eye (Lond); 2008 Jun; 22(6):815-8. PubMed ID: 17277751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of hyaloid-retinal relationship during triamcinolone-assisted vitrectomy for primary rhegmatogenous retinal detachment.
    Sundar D; Takkar B; Venkatesh P; Chawla R; Temkar S; Azad SV; Vohra R
    Eur J Ophthalmol; 2018 Sep; 28(5):607-613. PubMed ID: 29569478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combined use of perfluorohexyloctane (F6H8) and silicone oil as an intraocular tamponade in the treatment of severe retinal detachment.
    Rizzo S; Genovesi-Ebert F; Belting C
    Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):709-16. PubMed ID: 16550400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitreous substitutes: An overview of the properties, importance, and development.
    Yadav I; Purohit SD; Singh H; Bhushan S; Yadav MK; Velpandian T; Chawla R; Hazra S; Mishra NC
    J Biomed Mater Res B Appl Biomater; 2021 Aug; 109(8):1156-1176. PubMed ID: 33319466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11.
    Abrams GW; Azen SP; McCuen BW; Flynn HW; Lai MY; Ryan SJ
    Arch Ophthalmol; 1997 Mar; 115(3):335-44. PubMed ID: 9076205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient postvitrectomy fluid-gas exchange using long-acting gasses.
    Devenyi RG
    Can J Ophthalmol; 1995 Apr; 30(3):148. PubMed ID: 7627901
    [No Abstract]   [Full Text] [Related]  

  • 35. [Vitreoretinal interface: pathophysiological, morphological and functional aspects].
    Haritoglou C
    Ophthalmologe; 2015 Jan; 112(1):8-9. PubMed ID: 25583418
    [No Abstract]   [Full Text] [Related]  

  • 36. Silicone oil and fluorosilicone.
    Yamamoto S; Takeuchi S
    Semin Ophthalmol; 2000 Mar; 15(1):15-24. PubMed ID: 10749311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proliferative Vitreoretinopathy: Therapeutic Strategies].
    Schaub F; Enders P; Fauser S
    Klin Monbl Augenheilkd; 2016 Sep; 233(9):1016-23. PubMed ID: 27479579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Principal vitreo-retinal disorders treated with vitrectomy].
    Bovey EH
    Rev Med Suisse Romande; 1996 Jan; 116(1):45-9. PubMed ID: 8871274
    [No Abstract]   [Full Text] [Related]  

  • 39. An endoscopic overview of the anterior vitreous base in retinal detachment and anterior proliferative vitreoretinopathy.
    Boscher C; Kuhn F
    Acta Ophthalmol; 2014 Jun; 92(4):e298-304. PubMed ID: 24428936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term vitreous replacement with perfluorohexyloctane and silicone oil: preliminary reports of a multicentric study.
    Rizzo S; Genovesi-Ebert F; Belting C; Foltran F; Gandolfo E; Lesnoni G; Dell'omo E; Zenoni S; Azzolini M; De Molfetta V
    Ophthalmologica; 2005; 219(3):147-53. PubMed ID: 15947500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.